Nov. 18 SessionRegistration opens Nov. 1, 2021.
This month, the selected study explores the longevity of vaccine-elicited immunity to SARS-CoV-2 variants of concern. Our presenter and panelists, with their diverse expertise, will lead an in-depth discussion about the role of vaccine-induced T cell immune responses for providing durable protection against emerging variants.
Article under discussion: "mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status."
Authors: Jason Neidleman, Xiaoyu Luo, Matthew McGregor, Guorui Xie, Victoria Murray, Warner C. Greene, Sulggi A. Lee and Nadia R. Roan.
This article is distributed under the terms of the Creative Commons Attribution License.
University of California Irvine
Sonia Navas-Martin, Ph.D.
Drexel University College of Medicine
Michael Betts, Ph.D.
Perelman School of Medicine, University of Pennsylvania
Alba Grifoni, Ph.D.
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Andrés Finzi, Ph.D.
CHUM Research Center, University of Montréal
Jan. 20, 2022, 2 p.m. ET (registration will open Jan. 1, 2022).
Missed a past session?
Recordings are available free to ASM members.